Pentamidine Interactions

18 interactions on record

Concomitant use may cause severe hypocalcemia and renal impairment; one patient death reported with severe hypocalcemia.

Source: NLP:foscarnet sodium

Associated with myelosuppression or nephrotoxicity; coadministration should be considered only if potential benefits outweigh risks.

Source: NLP:ganciclovir sodium

Co-administration with valganciclovir should be considered only if potential benefits outweigh risks due to potential for higher toxicity from myelosuppression or nephrotoxicity.

Source: NLP:valganciclovir hydrochloride

Pentamidine impairs gastrointestinal folate uptake through mechanisms affecting folate absorption.

Source: NLP:folic acid

Associated with myelosuppression or nephrotoxicity. Coadministration considered only if benefits outweigh risks.

Source: NLP:ganciclovir

May cause hypoglycemia sometimes followed by hyperglycemia. Dose adjustment and increased glucose monitoring required.

Source: NLP:insulin aspart

May cause hypoglycemia sometimes followed by hyperglycemia. Dose adjustment and increased glucose monitoring may be required.

Source: NLP:insulin aspart-szjj

May cause hypoglycemia which may sometimes be followed by hyperglycemia. Dosage adjustment and increased glucose monitoring may be required.

Source: NLP:insulin degludec

May cause hypoglycemia followed by hyperglycemia; dosage adjustment and increased glucose monitoring may be required.

Source: NLP:insulin glargine

May cause hypoglycemia which may sometimes be followed by hyperglycemia. Dose adjustment and increased glucose monitoring required.

Source: NLP:insulin glulisine

May cause hypoglycemia followed sometimes by hyperglycemia; dose adjustment and glucose monitoring may be required.

Source: NLP:insulin human

May cause hypoglycemia followed sometimes by hyperglycemia; dose adjustment and increased glucose monitoring required.

Source: NLP:insulin lispro

May cause hypoglycemia sometimes followed by hyperglycemia. Dose adjustment and increased glucose monitoring may be required.

Source: NLP:insulin lispro-aabc

QT interval prolonging drug. Coadministration with VANFLYTA may further increase incidence of QT prolongation. More frequent ECG monitoring recommended.

Source: NLP:quizartinib

Drug associated with myelosuppression or nephrotoxicity. Consider coadministration only if potential benefits outweigh risks.

Source: NLP:valganciclovir

Suspected of causing SIADH; may increase pressor and antidiuretic effects of vasopressin. Hemodynamic monitoring recommended.

Source: NLP:vasopressin

May cause SIADH, increasing pressor and antidiuretic effects of vasopressin. Hemodynamic monitoring recommended; adjust vasopressin dose as needed.

Source: NLP:vasopressin in 0.9% sodium chloride